Article
Transdominant genetics, peptide inhibitors and drug targets.
Current opinion in molecular therapeutics - 1 Dec 2000
Kamb A, Teng D H
Abstract excerpt
The future of medical therapy is tied to the discovery of high-quality drug targets and drugs. Transdominant genetics provides a function-based route to peptide inhibitors that can be used as probes to identify protein targets or as reagents for drug development. Both forward-genetic and reverse-genetic applications have been implemented. The move is now underway to expand upon advances made in model systems and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
